Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy

Publisher Website

1 January 2000

journal article
Published by Elsevier in Kidney International

Vol. 57 (1) , 348-349
https://doi.org/10.1046/j.1523-1755.2000.00843.x

Abstract

No abstract available

Keywords

This publication has 2 references indexed in Scilit:

Management of IgA nephropathy: Evidence-based recommendations
Kidney International, 1999
Three‐year randomized controlled trial of dipyridamole and low‐dose warfarin in patients with IgA nephropathy and renal impairment
Nephrology, 1997